Long-term effect of intrathecal baclofen treatment on bone health and body composition after spinal cord injury: A case matched report

Table 2 Bone mineral density and bone mineral content for knee metaphysis and bone epiphysis of distal femur and proximal tibia in a case report with intrathecal baclofen treatment implantation and the case-matches with complete spinal cord injury

Region	RDFM	RPTM	LDFM	LPTM	RDFE	RPTE	LDFE	LPTE
Knee BMC
Case report	3.97	4.29	4.11	4.07	5.73	4.66	6.94	4.58
Case match 1	8.49	8.32	7.89	9.2	15.68	12.4	16.15	12.71
% change case to match 1	113.3	93.9	91.9	126.0	173.6	166.0	132.7	177.5
Case match 2	5.13	3.21	5.28	4.79	9.79	5.12	11.66	6.63
% change case to match 2	29.2	-25.1	28.4	17.7	70.8	9.8	68.0	44.7
Knee BMD
Case report	0.257	0.484	0.267	0.404	0.277	0.248	0.354	0.247
Case match 1	0.605	0.665	0.585	0.731	0.605	0.479	0.634	0.498
% change case to match 1	135.4	37.4	119.1	80.9	118.4	93.1	79.09	101.6
Case match 2	0.371	0.263	0.376	0.362	0.435	0.246	0.487	0.286
% change case to match 2	44.3	-45.6	40.8	-10.4	57.0	-0.8065	37.6	15.8

% change is the percentage changes in either bone mineral density or bone mineral content between the case report and either the case match 1 [2 years post- post-spinal cord injury (SCI)] or the case-match 2 (13-years post-SCI). BMC: Bone mineral content; BMD: Bone mineral density; RDFM: Right distal femur metaphysis; RPTM: Right proximal tibia metaphysis; LDFM: Left distal femur metaphysis; LPTM: Left proximal tibia metaphysis; RDFE: Right distal femur epiphysis; RPTE: Right proximal tibia epiphysis; LDFE: Left distal femur epiphysis; LPTE: Left proximal tibia epiphysis.